Callan Capital, LLC Amgen Inc Transaction History

Callan Capital, LLC

$1.42 Billion
Q3 2024

A detailed history of Callan Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Callan Capital, LLC holds 2,736 shares of AMGN stock, worth $805,834. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,736

Previous 2,649 3.28%

Holding current value

$805,834

Previous $827,000 6.53%

% of portfolio

0.06%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $26,916 - $29,352	87 Added 3.28%	2,736 $881,000
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $7,094 - $8,621	27 Added 1.03%	2,649 $827,000
Q1 2024 Oct 22, 2024	SELL	$268.87 - $324.56 $7,259 - $8,763	-27 Reduced 1.02%	2,622 $745,000
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $31,188 - $37,648	116 Added 4.63%	2,622 $745,000
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $35,030 - $39,519	137 Added 5.78%	2,506 $721,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $28,643 - $35,561	131 Added 5.85%	2,369 $636,000
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $5,785 - $6,840	27 Added 1.22%	2,238 $496,000
Q1 2023 Jun 13, 2023	BUY	$225.79 - $275.2 $1,354 - $1,651	6 Added 0.27%	2,211 $534,000
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $1,354 - $1,651	6 Added 0.27%	2,211 $534,000
Q4 2022 Jun 13, 2023	SELL	$229.03 - $291.01 $1,374 - $1,746	-6 Reduced 0.27%	2,205 $579,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $215,288 - $273,549	940 Added 74.31%	2,205 $579,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $58,359 - $65,819	260 Added 25.87%	1,265 $285,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $69,674 - $77,535	-302 Reduced 23.11%	1,005 $245,000
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $76,744 - $84,899	-350 Reduced 21.12%	1,307 $316,000
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $70,005 - $80,115	352 Added 26.97%	1,657 $373,000
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $8,490 - $9,948	40 Added 3.16%	1,305 $278,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $57,696 - $67,236	260 Added 25.87%	1,265 $315,000
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $183,151 - $242,908	1,005 New	1,005 $204,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.

Account

Callan Capital, LLC Amgen Inc Transaction History